PharmEasy: A difficult prognosis

Parent API Holdings seems to be banking on FOMO to raise public money at 500% more than what it was valued at nine months ago.

22 November, 202115 min
0
PharmEasy: A difficult prognosis

You may also like

Business
Story image

Can Meesho’s value-commerce playbook pass the IPO test?

The ecommerce platform will be hard-pressed to justify its estimated $7-8 billion valuation—up nearly 2x from just 10 months ago—at a time of ho-hum growth and flagging profitability.

Internet
Story image

A guide to understanding Dubizzle’s high-profile public listing

The popular classifieds company has just announced a public offering in Dubai and filed its prospectus. We take a look at its trajectory and timing.

Business
Story image

WeWork India: the IPO that could have been so much more

The co-working giant’s initial public offering is a missed opportunity that prioritizes promoter interests at the expense of incoming shareholders. Given this, the tepid investor interest is no surprise.